Base period and three (3) option periods, labor hour (LH) type task order to procure additive manufacturing of medical products core facility support for the food and drug administration (FDA), center…
Active Awarded Last action
- Contract number
- 75F40125F19015
- Awardee
-
Kaiva Strategies, LLC UEI HCWKVFGBPA64
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $354,067
Award facts
- Contract value 51% obligated
-
- $354,067.20 Current, with exercised options
- $697,180.00 Potential, with all options
- Completion date 36% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- Competitive 8(a)
- Competition
- Full and Open Competition after exclusion of sources Negotiated Proposal / Quote
- Pricing
- Labor Hours
- Place of performance
- Silver Spring, MD 20993, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $179,654 | |
| Original award | $174,413 |
About this award
The Food and Drug Administration issued a delivery order to Kaiva Strategies, LLC, a tribally-owned, minority-owned 8(a) small business, on September 23, 2025, under the Professional, Administrative, and Consulting Services (PACS) IDIQ with a ceiling value of $697,180 for additive manufacturing of medical products core facility support to the FDA's Center for Devices and Radiological Health.
The PACS IDIQ is a $100 million Competitive 8(a) single-award vehicle supporting professional, administrative, and consulting services across FDA, running through August 2028. This delivery order is labor-hour priced with a base period and three option periods, performing in Silver Spring, MD through September 22, 2028. Kaiva Strategies operates primarily as a managed service delivery vehicle, with subcontractors performing approximately 70 percent of contractor hours across its SCI-reportable prime contracts at median government-paid rates around $113.91 per hour.
Description
Base period and three (3) option periods, labor hour (LH) type task order to procure additive manufacturing of medical products core facility support for the food and drug administration (FDA), center for devices and radiological health (cdrh) and of
Quick answers
Who was awarded contract 75F40125F19015?
75F40125F19015 was awarded to Kaiva Strategies, LLC by Food and Drug Administration (Department of Health and Human Services) on September 23, 2025.
How much is contract 75F40125F19015 worth?
The government has obligated $354,067 on 75F40125F19015. Its potential value, with all options, is $697,180.
Is contract 75F40125F19015 an order under another contract?
Yes. 75F40125F19015 is a delivery order under 75F40123D00021, an indefinite delivery contract.
Was contract 75F40125F19015 competed?
The extent of competition for 75F40125F19015 was full and open competition after exclusion of sources. It was set aside: Competitive 8(a).
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award